Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Shares Issued (2016 - 2025)

Biomerica's Shares Issued history spans 14 years, with the latest figure at $493000.0 for Q4 2025.

  • For Q4 2025, Shares Issued changed N/A year-over-year to $493000.0; the TTM value through Nov 2025 reached $1.1 million, changed N/A, while the annual FY2025 figure was $15000.0, N/A changed from the prior year.
  • Shares Issued for Q4 2025 was $493000.0 at Biomerica, down from $939000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $2.4 million in Q2 2022 and bottomed at -$2.1 million in Q2 2025.
  • The 4-year median for Shares Issued is $736166.5 (2021), against an average of $558355.1.
  • The largest YoY upside for Shares Issued was 5526.4% in 2021 against a maximum downside of 732.69% in 2021.
  • A 4-year view of Shares Issued shows it stood at $912889.0 in 2021, then surged by 110.65% to $1.9 million in 2022, then tumbled by 102.76% to -$53000.0 in 2023, then surged by 1030.19% to $493000.0 in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Shares Issued are $493000.0 (Q4 2025), $939000.0 (Q3 2025), and -$2.1 million (Q2 2025).